Chinese CDMO contracted to manufacture Pfizer’s oncology candidate
CMAB Biopharma to support Kintor in the clinical development of a potential treatment for liver cancer, ahead of regulatory filing.
Archives for August 27, 2019
J&J ordered to pay $572m for the opioid crisis, prepares to appeal
J&J is ordered to pay $572m to the state of Oklahoma, after a court judgement found against the pharmaceutical company for its role in the opioid crisis.
PCI boosts Ireland investment pre-Brexit with new clinical facility
As part of its global network expansion strategy, PCI Pharma Services is investing in a new dedicated clinical facility near Dublin, Ireland, which will provide space for secondary packaging, storage, logistics, and distribution.
Amgen sees ‘strategic fit’ for $13.4bn Otezla
Amgen confirms that it will acquire blockbuster psoriasis treatment Otezla, freeing BMS and Celgene to complete their merger deal by the end of 2019.
Cellular therapy CDMO Cognate closes growth capital round
Cognate BioServices closes a round of growth capital from EW Healthcare Partners to secure its capabilities for the commercialization of advanced cellular therapies.
PPD signed on as preferred provider for Harbour BioMed
Harbour BioMed has selected PPD as its preferred CRO partner as part of a strategic collaboration to develop novel oncology and immunology therapeutics.
Virtual research platform Thread acquired by strategic investors
As the industry focuses on modernizing clinical research, Thread is set to continue expanding its virtual research platform after today announcing its acquisition by strategic investors, says company executive.